Evidence map›Paper›PMID 36323792›Full record

ArticleNature biotechnology2022

The Coronavirus Standards Working Group's roadmap for improved population testing.

Tim Mercer, Neil Almond, Michael A Crone, Patrick S G Chain, Alina Deshpande, Deepa Eveleigh, Paul Freemont, Sebastien Fuchs, Russell Garlick, Jim Huggett and 17 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Tim MercerAustralian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, Queensland, Australia.
Neil AlmondMedicines and Healthcare Products Regulatory Agency, Potters Bar, UK.
Michael A CroneLondon Biofoundry, Imperial College Translation and Innovation Hub, London, UK.ORCID http://orcid.org/0000-0002-5675-0172
Patrick S G ChainBiosecurity and Public Health, Bioscience Division, Los Alamos National Laboratory, Los Almos, NM, USA.ORCID http://orcid.org/0000-0003-3949-3634
Alina DeshpandeBiosecurity and Public Health, Bioscience Division, Los Alamos National Laboratory, Los Almos, NM, USA.
Deepa EveleighBio-techne, Inc, Austin, TX, USA.
Paul FreemontLondon Biofoundry, Imperial College Translation and Innovation Hub, London, UK.ORCID http://orcid.org/0000-0002-5658-8486
Sebastien FuchsWestern University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona, CA, USA.
Russell GarlickLGC Clinical Diagnostics, Milford, MA, USA.
Jim HuggettNational Measurement Laboratory, LGC, Teddington, UK.
Martin KammelINSTAND e.V. Society for Promoting Quality Assurance in Medical Laboratories, Duesseldorf, Germany.ORCID http://orcid.org/0000-0002-2011-086X
Po-E LiBiosecurity and Public Health, Bioscience Division, Los Alamos National Laboratory, Los Almos, NM, USA.
Mojca MilavecDepartment of Biotechnology and Systems Biology, National Institute of Biology, Ljubljana, Slovenia.ORCID http://orcid.org/0000-0002-5794-2109
Elizabeth M MarloweQuest Diagnostic Infectious Disease, San Juan Capistrano, CA, USA.
Denise M O'SullivanNational Measurement Laboratory, LGC, Teddington, UK.
Mark PageMedicines and Healthcare Products Regulatory Agency, Potters Bar, UK.
Gary A PestanoBiodesix Inc, Boulder, CO, USA.
Sara SulimanBrigham and Women's Hospital, Division of Rheumatology, Inflammation and Immunity, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5154-576X
Birgitte SimenGinkgo Bioworks, Boston, MA, USA.
John J SninskySPARK, Stanford University, Stanford, CA, USA.
Lynne SopchakSPARK, Stanford University, Stanford, CA, USA.
Cristina M TatoChan Zuckerberg Biohub, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-0614-756X
Peter M ValloneBiomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD, USA.ORCID http://orcid.org/0000-0002-8019-6204
Jo VandesompeleCellCarta, Zwijnaarde, Belgium.
Thomas J WhiteHuman Rights Center, School of Law, University of California, Berkeley, CA, USA.ORCID http://orcid.org/0000-0001-5880-128X
Heinz ZeichhardtINSTAND e.V. Society for Promoting Quality Assurance in Medical Laboratories, Duesseldorf, Germany.
Marc SalitDepartments of Pathology and Bioengineering, Stanford University, Stanford, CA, USA. msalit@stanford.edu.ORCID http://orcid.org/0000-0003-1624-5195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronavirus

Identifiers

PMID36323792
PMCPMC9628457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.